Cargando…
Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study
The immunogenicity of vaccines decreases over time, causing a need for booster doses. This study aimed to present the long-term (Day 84) immunogenicity results of the double-blind, randomized, controlled, phase II Hybrid COV-RAPEL TR Study (NCT04979949), in which the TURKOVAC or CoronaVac vaccines w...
Autores principales: | Ates, Ihsan, Batirel, Ayse, Aydin, Mehtap, Karadag, Fatma Yilmaz, Erden, Abdulsamet, Kucuksahin, Orhan, Armagan, Berkan, Guven, Serdar Can, Karakas, Ozlem, Gokdemir, Selim, Altunal, Lutfiye Nilsun, Buber, Aslihan Ayse, Gemcioglu, Emin, Zengin, Oguzhan, Inan, Osman, Sahiner, Enes Seyda, Korukluoglu, Gulay, Sezer, Zafer, Ozdarendeli, Aykut, Omma, Ahmet, Kara, Ates |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416156/ https://www.ncbi.nlm.nih.gov/pubmed/37515050 http://dx.doi.org/10.3390/vaccines11071234 |
Ejemplares similares
-
Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial
por: Omma, Ahmet, et al.
Publicado: (2022) -
A single center experience of intravenous immunoglobulin treatment in Covid-19
por: Omma, Ahmet, et al.
Publicado: (2021) -
Convalescent Plasma Reduces Endogenous Antibody Response in COVID-19: A Retrospective Cross-Sectional Study
por: Omma, Ahmet, et al.
Publicado: (2021) -
Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study
por: KÜÇÜKŞAHİN, Orhan, et al.
Publicado: (2022) -
COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis?
por: Özdemir, Bahar, et al.
Publicado: (2021)